Better Growth Play: Merck or The Vanguard Growth Index Fund?
Merck’s shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Mindfully Curated
Merck’s shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
The pharmaceutical giant is laying the groundwork for its next heyday.
These funds deliver a great mix of income and capital appreciation.
This small biotech is struggling to fly — and investors should probably steer clear.
Dividend stocks can be a smart way to ride out market volatility.
This top-performing semiconductor exchange-traded fund’s (ETF’s) largest holding is Nvidia stock, which accounts for 20% of its total portfolio.
It’s America’s favorite retailer for good reason — and the stock price reflects it.
The worst could be over, but is that enough to justify buying it?
Comcast’s Epic Universe is going to live up to its name, but that doesn’t mean Disney won’t win.
Uranium Energy stock is skyrocketing from a growth driver that could persist for decades.
Knowing these differences is key to deciding which is right for you.
Get more diversification by putting these ETFs in your portfolio.
Solid returns, low costs, and broad diversification are key attributes of this fund.
These chip leaders are profitable companies with above-average growth prospects.
Shares of this fintech operator are rising with the overall market.
Bitcoin’s evolution over the last half-decade positions it for a compelling future.
With the right approach, you can lower your chances of struggling financially later in life.
These companies have proven themselves in the past — and could go on to win in the future.
Most recipients won’t have to pay state taxes on their benefits, but federal tax rules apply to everyone.
It’s never an ideal answer. As of early 2024, however, it’s a particularly bad idea for reasons that are rarely this decided.